Bone Metastasis: Elderly Patients Drifting Toward Unproven Treatments
With alkaline phosphatase 20 times higher and no primary tumor found, an octogenarian's family turns to CDS and ivermectin.
English · Original discussion in Spanish · Published
Bone Metastasis: Elderly Patients Drifting Toward Unproven Treatments
When a patient over 80 is diagnosed with bone metastases without finding the primary tumor, conventional medicine faces a guarded prognosis. But alongside the hospital process — involving CT scans, tests, and suspicion of neuroendocrine cancer — a increasingly documented phenomenon emerges: families seeking alternative solutions. In this case, chlorine dioxide solution (CDS), ivermectin, and vitamin supplements entered the scene before oncologists defined the treatment.
Why are unconventional therapies growing?
Distrust in the healthcare system is the fuel. Digital environments proliferate stories of patients claiming to have reversed metastases with ketogenic diets, fasting, or antiparasitics. Some options, like CDS or MMS, have triggered health alerts due to toxicity. However, the urgency of the diagnosis — alkaline phosphatase 20 times above normal — and the feeling that official medicine offers no immediate answers push relatives to explore everything found online.
Some argue advanced age works in their favor: cancer in those over 80 often pogre slower, and adequate palliative care can achieve a dignified quality of life. At the other extreme, defenders of alternative treatments claim conventional chemotherapy is a business and natural protocols have scientific basis. The reality is that no solid study supports using chlorine dioxide for cancer, and administering ivermectin or febendazole lacks oncological authorization.
The risk of self-medication in bone metastases
The medical community warns that intervening without diagnosis can worsen the condition. In an elderly patient with diffuse bone lesions, the risk of renal toxicity, dehydration, or drug interactions multiplies. The case of the patient receiving morphine upon admission — later withdrawn due to her lucid state — illustrates the delicate balance between pain and side effects.
Some professionals offer to review imaging tests to help guide the diagnosis, revealing that even within the system there is a desire to collaborate beyond protocol. But the unanimous message is: wait to identify the primary tumor before any decision.
The price of hope
Alternative treatments have economic costs not covered by social security. CDS, supplements, and private consultations can represent significant outlays for families, while public healthcare offers free care. The equation between investing in unsupported options or accepting medicine's limits is as personal as it is unsolvable.
We foresee that, lacking a certain diagnosis and under emotional pressure, many families will continue opting to mix conventional with alternative approaches. The challenge is not medical, but one of communication and trust. Until oncology provides rapid and humanized answers, the breeding ground for miracle cures will continue to grow.
When a patient over 80 is diagnosed with bone metastases without finding the primary tumor, conventional medicine faces a guarded prognosis. But alongside the hospital process — involving CT scans, tests, and suspicion of neuroendocrine cancer — a increasingly documented phenomenon emerges: families seeking alternative solutions. In this case, chlorine dioxide solution (CDS), ivermectin, and vitamin supplements entered the scene before oncologists defined the treatment.
Why are unconventional therapies growing?
Distrust in the healthcare system is the fuel. Digital environments proliferate stories of patients claiming to have reversed metastases with ketogenic diets, fasting, or antiparasitics. Some options, like CDS or MMS, have triggered health alerts due to toxicity. However, the urgency of the diagnosis — alkaline phosphatase 20 times above normal — and the feeling that official medicine offers no immediate answers push relatives to explore everything found online.
Some argue advanced age works in their favor: cancer in those over 80 often pogre slower, and adequate palliative care can achieve a dignified quality of life. At the other extreme, defenders of alternative treatments claim conventional chemotherapy is a business and natural protocols have scientific basis. The reality is that no solid study supports using chlorine dioxide for cancer, and administering ivermectin or febendazole lacks oncological authorization.
The risk of self-medication in bone metastases
The medical community warns that intervening without diagnosis can worsen the condition. In an elderly patient with diffuse bone lesions, the risk of renal toxicity, dehydration, or drug interactions multiplies. The case of the patient receiving morphine upon admission — later withdrawn due to her lucid state — illustrates the delicate balance between pain and side effects.
Some professionals offer to review imaging tests to help guide the diagnosis, revealing that even within the system there is a desire to collaborate beyond protocol. But the unanimous message is: wait to identify the primary tumor before any decision.
The price of hope
Alternative treatments have economic costs not covered by social security. CDS, supplements, and private consultations can represent significant outlays for families, while public healthcare offers free care. The equation between investing in unsupported options or accepting medicine's limits is as personal as it is unsolvable.
We foresee that, lacking a certain diagnosis and under emotional pressure, many families will continue opting to mix conventional with alternative approaches. The challenge is not medical, but one of communication and trust. Until oncology provides rapid and humanized answers, the breeding ground for miracle cures will continue to grow.
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (156 replies).
More summaries
-
Invega Hafyera: Six-Month Injection Sparks Psychiatric Debate
Johnson & Johnson's Invega Hafyera, a six-month antipsychotic injection with no antidote, reignites debate on psychiatric limits and control.
-
Rural Life in 1930: Myth vs. Reality of an 800kg Cow
Rural life in 1930 wasn't the idyll often sold; from Irish famine to midnight calving.
-
Beatriz Montañez's Lugo Cabin Sparks Debate Over Rural Authenticity
Spanish TV personality Beatriz Montañez defends her rural retreat in Lugo, but critics question the authenticity of a 'cabin' equipped with Wi-Fi and manicured nails.
-
Pork loin cheaper than chicken in Spain
A forum user estimates pork loin at €6/kg and chicken near €9€, sparking debate on protein cost per gram.
-
Edible Birds in Hard Times: From Sparrows to Gulls
Sparrows, thrushes, gulls and owls were eaten during food shortages. Here is which birds are worth cooking.
-
OpenAI Leak Suggests AI Could Run Companies by 2030
A forum discusses the leaked Strawberry project, claiming AGI could manage businesses by 2030. Debates focus on universal basic income and job displacement.